Market Cap 143.00B
Revenue (ttm) 63.63B
Net Income (ttm) 8.03B
EPS (ttm) N/A
PE Ratio 7.86
Forward PE 7.92
Profit Margin 12.62%
Debt to Equity Ratio 0.66
Volume 35,453,900
Avg Vol 73,066,328
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 81%
Beta 0.46
Analysts Sell
Price Target $28.43

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and tre...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
Willieberich
Willieberich Dec. 5 at 3:55 PM
$PFE conspiracy bot ...all garbage news ..
0 · Reply
Bluewin
Bluewin Dec. 5 at 3:53 PM
$MRNA $PFE should buy $MRNA
0 · Reply
Willieberich
Willieberich Dec. 5 at 3:53 PM
$PFE looks like someone finally opened there wallet..
0 · Reply
taxplanr
taxplanr Dec. 5 at 3:36 PM
Just in case you don't believe ACIP is closing the door on malignantRNA bioweapons from $BNTX $MRNA $PFE $NVAX there's this going on in FL courts https://www.josephsansone.com/p/mrna-bioweapons-prohibition-case-138?utm_source=post-email-title&publication_id=1021940&post_id=180755803&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
1 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Dec. 5 at 3:36 PM
$SLS as an FYI while we are waiting for Imminently DUE GPS Registrational Phase 3 Results... We will be Seeing Some data for SLS009 on Monday 009 is in the Same Class as Several Well Known Blockbusters: $SLS SLS009 - Tambiciclib CDKinase Inhibitor $PFE Pfizers' IBRANCE - Palbociclib CDKinase Inhibitor Novartis' KISQALI -Ribociclib CDKinase Inhibitor Eli Lilly's VERZENIO - Abemaciclib CDKinase Inhibitor - REGOR's Phase 1 - Phase 1 CDKinase Assets were bought for $850M in Cash +$4B More in Milestones. Just the Secondary SLS Asset is worth 10 -20x the current Market Cap.
0 · Reply
ZacksResearch
ZacksResearch Dec. 5 at 3:16 PM
$CRMD: Dominating the niche, but can it fend off giants? DefenCath, the only FDA-approved CRBSI solution, is a key driver of $CRMD's robust growth, with $167.6M in sales in the first 9 months of 2025. However, looming competition from big players like $PFE and $AMPH could challenge its market lead. Discover why CRMD remains a Buy with a Zacks Rank #2 👉 https://www.zacks.com/stock/news/2800190/can-defencath-continue-to-aid-cormedixs-long-term-growth-ahead?cid=sm-stocktwits-2-2800190-body-23631&ADID=SYND_STOCKTWITS_TWEET_2_2800190_BODY_23631
1 · Reply
Micheal_Pothead
Micheal_Pothead Dec. 5 at 3:14 PM
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 5 at 2:43 PM
Enter: $PFE Calls Strike Price: $26 Expiry Date: DEC 26 2025 Buy in Price: $0.49 - $0.50 Sell Price: $0.92 Profit : +87% (Turn every $1 into $1.87) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
Namhguab
Namhguab Dec. 5 at 2:38 PM
$PFE I have literally grown to hate this stock
1 · Reply
knuckleheadinvestco
knuckleheadinvestco Dec. 5 at 2:31 PM
$PFE let’s run to 26 this morning
0 · Reply
Latest News on PFE
Pfizer: The Market Is Still Wrong About It

Dec 5, 2025, 9:00 AM EST - 2 hours ago

Pfizer: The Market Is Still Wrong About It


2 Top Dividend Stocks to Buy Now and Hold For a Decade

Dec 2, 2025, 7:44 AM EST - 3 days ago

2 Top Dividend Stocks to Buy Now and Hold For a Decade

ABBV


This 7% Yielder Could Be a Top AI Play

Nov 30, 2025, 4:04 PM EST - 4 days ago

This 7% Yielder Could Be a Top AI Play


8 Dividend Stocks Every Investor Should Consider

Nov 28, 2025, 5:30 AM EST - 7 days ago

8 Dividend Stocks Every Investor Should Consider

ABBV AXP COST JPM NVDA PM SPGI


Final Trade: DAL, AXP, PFE, HMY

Nov 26, 2025, 6:20 PM EST - 8 days ago

Final Trade: DAL, AXP, PFE, HMY

AXP DAL HMY


Did Pfizer Just Say "Checkmate" to Novo Nordisk?

Nov 26, 2025, 4:15 AM EST - 9 days ago

Did Pfizer Just Say "Checkmate" to Novo Nordisk?


Is This the Best Value Stock to Buy While Markets Are Volatile?

Nov 25, 2025, 6:24 AM EST - 10 days ago

Is This the Best Value Stock to Buy While Markets Are Volatile?


Pfizer Crosses Below Key Moving Average Level

Nov 20, 2025, 4:05 PM EST - 14 days ago

Pfizer Crosses Below Key Moving Average Level


Is Pfizer's 6.9%-Yielding Dividend Still Safe?

Nov 20, 2025, 9:30 AM EST - 15 days ago

Is Pfizer's 6.9%-Yielding Dividend Still Safe?


Pfizer: Is This Pharma Giant Finally A Bargain

Nov 19, 2025, 3:51 PM EST - 15 days ago

Pfizer: Is This Pharma Giant Finally A Bargain


Pfizer in $41.5 million settlement with Texas over ADHD drug

Nov 19, 2025, 10:31 AM EST - 16 days ago

Pfizer in $41.5 million settlement with Texas over ADHD drug


2 No-Brainer Healthcare Stocks to Buy Now

Nov 18, 2025, 6:45 AM EST - 17 days ago

2 No-Brainer Healthcare Stocks to Buy Now

VKTX


Pfizer's CEO Sends a Warning to Eli Lilly. Is the Stock a Buy?

Nov 17, 2025, 9:10 PM EST - 17 days ago

Pfizer's CEO Sends a Warning to Eli Lilly. Is the Stock a Buy?


2 Giant Healthcare Stocks to Buy Hand Over Fist in November

Nov 17, 2025, 10:00 AM EST - 18 days ago

2 Giant Healthcare Stocks to Buy Hand Over Fist in November

MDT


Down 55%, Should You Buy the Dip on Pfizer?

Nov 17, 2025, 4:35 AM EST - 18 days ago

Down 55%, Should You Buy the Dip on Pfizer?


Is Pfizer Stock a Buy After This $10 Billion Acquisition?

Nov 15, 2025, 5:45 AM EST - 20 days ago

Is Pfizer Stock a Buy After This $10 Billion Acquisition?


Activist Starboard sells Pfizer stake after pushing for changes

Nov 14, 2025, 6:33 PM EST - 20 days ago

Activist Starboard sells Pfizer stake after pushing for changes


Pfizer CEO: RFK Jr. "clearly" was not his HHS Secretary choice

Nov 13, 2025, 2:16 PM EST - 21 days ago

Pfizer CEO: RFK Jr. "clearly" was not his HHS Secretary choice


Pfizer CEO: AI will help with medicine's next big breakthrough

Nov 13, 2025, 1:07 PM EST - 21 days ago

Pfizer CEO: AI will help with medicine's next big breakthrough


Pfizer Completes Acquisition of Metsera

Nov 13, 2025, 11:26 AM EST - 21 days ago

Pfizer Completes Acquisition of Metsera

MTSR


BioNTech says collaboration with Pfizer remains unchanged

Nov 13, 2025, 8:17 AM EST - 22 days ago

BioNTech says collaboration with Pfizer remains unchanged

BNTX


3 Healthcare Stocks Topping a 2025 List of Dividend Yields

Nov 12, 2025, 8:27 PM EST - 22 days ago

3 Healthcare Stocks Topping a 2025 List of Dividend Yields

BMY XRAY


Willieberich
Willieberich Dec. 5 at 3:55 PM
$PFE conspiracy bot ...all garbage news ..
0 · Reply
Bluewin
Bluewin Dec. 5 at 3:53 PM
$MRNA $PFE should buy $MRNA
0 · Reply
Willieberich
Willieberich Dec. 5 at 3:53 PM
$PFE looks like someone finally opened there wallet..
0 · Reply
taxplanr
taxplanr Dec. 5 at 3:36 PM
Just in case you don't believe ACIP is closing the door on malignantRNA bioweapons from $BNTX $MRNA $PFE $NVAX there's this going on in FL courts https://www.josephsansone.com/p/mrna-bioweapons-prohibition-case-138?utm_source=post-email-title&publication_id=1021940&post_id=180755803&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
1 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Dec. 5 at 3:36 PM
$SLS as an FYI while we are waiting for Imminently DUE GPS Registrational Phase 3 Results... We will be Seeing Some data for SLS009 on Monday 009 is in the Same Class as Several Well Known Blockbusters: $SLS SLS009 - Tambiciclib CDKinase Inhibitor $PFE Pfizers' IBRANCE - Palbociclib CDKinase Inhibitor Novartis' KISQALI -Ribociclib CDKinase Inhibitor Eli Lilly's VERZENIO - Abemaciclib CDKinase Inhibitor - REGOR's Phase 1 - Phase 1 CDKinase Assets were bought for $850M in Cash +$4B More in Milestones. Just the Secondary SLS Asset is worth 10 -20x the current Market Cap.
0 · Reply
ZacksResearch
ZacksResearch Dec. 5 at 3:16 PM
$CRMD: Dominating the niche, but can it fend off giants? DefenCath, the only FDA-approved CRBSI solution, is a key driver of $CRMD's robust growth, with $167.6M in sales in the first 9 months of 2025. However, looming competition from big players like $PFE and $AMPH could challenge its market lead. Discover why CRMD remains a Buy with a Zacks Rank #2 👉 https://www.zacks.com/stock/news/2800190/can-defencath-continue-to-aid-cormedixs-long-term-growth-ahead?cid=sm-stocktwits-2-2800190-body-23631&ADID=SYND_STOCKTWITS_TWEET_2_2800190_BODY_23631
1 · Reply
Micheal_Pothead
Micheal_Pothead Dec. 5 at 3:14 PM
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 5 at 2:43 PM
Enter: $PFE Calls Strike Price: $26 Expiry Date: DEC 26 2025 Buy in Price: $0.49 - $0.50 Sell Price: $0.92 Profit : +87% (Turn every $1 into $1.87) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
Namhguab
Namhguab Dec. 5 at 2:38 PM
$PFE I have literally grown to hate this stock
1 · Reply
knuckleheadinvestco
knuckleheadinvestco Dec. 5 at 2:31 PM
$PFE let’s run to 26 this morning
0 · Reply
dogDazeSummer
dogDazeSummer Dec. 5 at 1:02 PM
$IFRX sure wld be nice if we had a little Gohibic on home turf w strongest approval. The right pharmaceutical company with the right marketing approach & EU distribution could generate value with this drug. The drug sales rep cld say: “would you like fries with that? (Sorry, US analogy)….OR “You know we also carry Gohibic now- wld u like 20 or 50 with this weeks order?” Easiest sale is a new product to existing customer (worst being new product to new—old customer). And prolly pick up entire company for reasonable cash ~$700-$1.1b Given timeline, the odds are growing by the day. BARDA, PG, Gohibic, next gen molecule are all “sleeper assets”. Patients/ Patience. $ABBV $PFE $RHHBY https://www.telegraph.co.uk/global-health/science-and-disease/eu-pre-pandemic-plan-to-stop-bird-flu-jumping-to-humans/
1 · Reply
Turkeymilitary
Turkeymilitary Dec. 5 at 7:42 AM
1 · Reply
bio1275
bio1275 Dec. 5 at 5:31 AM
$PFE unexpectedly well the last two trading sessions. good
0 · Reply
victorgn
victorgn Dec. 5 at 4:26 AM
$PFE $XOM $CVX https://dive2stocks.blogspot.com/2025/12/top-50-market-cap-stocks-in-low-25-of.html
0 · Reply
Jimmyboy29
Jimmyboy29 Dec. 5 at 3:53 AM
$PFE nice little bull flag for the 1month
0 · Reply
JoeTheMiner
JoeTheMiner Dec. 5 at 12:33 AM
$GUTS $SLS Bought again today at 1.9 This is a candidate for takeover for $PFE $NVO or $NVS I hope for a $5BILLION takeover. It is the perfect fit for drug like ozempic. Work in tandem Why peter Thiel is shareholder? 🤫🧐
3 · Reply
TQQQQ
TQQQQ Dec. 4 at 11:28 PM
$PFE https://stocktwits.com/news-articles/markets/equity/trump-administration-deadline-pharma-investments-to-end-of-term/cLIicqBREj4
0 · Reply
JoeTheMiner
JoeTheMiner Dec. 4 at 10:33 PM
$GUTS we are legion, We will see this raise to 8$ We will see have 50000 watchers Fasten your seat belt Hello $PFE , We welcome a takeover at 8$ GUTS has +30 patents
1 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Dec. 4 at 9:24 PM
$SLS as an FYI while we are waiting for Imminently DUE GPS Registrational Phase 3 Results... We will be Seeing Some data for SLS009 on Monday 009 is in the Same Class as Several Well Known Blockbusters SLS009 - Tambiciclib CDKinase Inhibitor $PFE Pfizers' IBRANCE - Palbociclib CDKinase Inhibitor Novartis' KISQALI -Ribociclib CDKinase Inhibitor Eli Lilly's VERZENIO - Abemaciclib CDKinase Inhibitor and Don't Forget REGOR's Phase 1 CDKinase Asset was bought for $850M in Cash +$4B More in Milestones. Just the Secondary SLS Asset is worth 10 -20x the current Market Cap.
0 · Reply
BrendaGarrett356
BrendaGarrett356 Dec. 4 at 9:01 PM
$PFE offers a defensive edge - pharma + dividend stability make it a smart hedge if markets stay choppy or take a breather.
1 · Reply
ParabolicUptrends
ParabolicUptrends Dec. 4 at 8:55 PM
Micro float SNSE is getting a lot of attention! Could be the next crazy runner! Never chase those big runners that are up 100%+ .. Easy way to lose! Key is to buy early before the runs happen! 💎 These tiny float tickers are running 100-400% recently! SNSE starting to get discovered and trending on Stocktwits! Only 500k shares outstanding - keep it on watch bulls! Hold $CLOV $RVSN $INTC $PFE calls
1 · Reply
up2moon
up2moon Dec. 4 at 8:52 PM
$PFE What's up? Why are we not tanking as usual? And Lilly below trilly...😦
0 · Reply